Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

anti-BCMA + anti-GPRC5D CAR-T cell therapy (multiple myeloma)

Home Drugsanti-BCMA + anti-GPRC5D CAR-T cell therapy (multiple myeloma)

anti-BCMA + anti-GPRC5D CAR-T cell therapy (multiple myeloma)

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Chimeric antigen receptor simultaneously targeting GPRC5D and CS1 and application thereof
CN 119548624 AApplicant: JIANGSU TUOHONG KANGHENG PHARMACEUTICAL CO LTDPriority: 2024
CN
METHODS FOR TREATING MULTIPLE MYELOMA WITH CAR-T CELLS AND BISPECIFIC ANTIBODIES
US 20260041768 A1Applicant: JANSSEN BIOTECH INCPriority: 2025
US